Literature DB >> 10208283

Adult Leigh syndrome with mitochondrial DNA mutation at 8993.

T Nagashima1, M Mori, K Katayama, M Nunomura, H Nishihara, H Hiraga, S Tanaka, Y Goto, K Nagashima.   

Abstract

Adult onset Leigh syndrome with a nucleotide (nt) 8993 mutation in mitochondrial (mt) DNA is reported. A 43-year-old woman with a 6-year-history of insulin-resistant diabetes mellitus developed muscular weakness, intractable nausea and vomiting, and anemia. These were followed vertigo, blindness, and deafness with nystagmus. Magnetic resonance imaging (MRI) revealed abnormal high intensities in the bilateral medial regions of the thalamus and periaqueductal gray matters. Autopsy disclosed well-demarcated necrotizing lesions with prominent capillaries in the areas detected by MRI, which were sufficiently diagnostic for Leigh syndrome. MtDNA analysis performed on DNAs extracted from formalin-fixed tissues including liver, heart, brain, muscle, kidney and pancreas showed a T-->G mutation at nt 8993. This is the first case of adult Leigh syndrome demonstrating on mtDNA mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208283     DOI: 10.1007/s004010051007

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome.

Authors:  Albert Quintana; Shane E Kruse; Raj P Kapur; Elisenda Sanz; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

3.  Medical treatment with thiamine, coenzyme Q, vitamins E and C, and carnitine improved obstructive sleep apnea in an adult case of Leigh disease.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Vasileios Mastorodemos; Andreas Plaitakis; Vangelis Alogdianakis; Nikolaos Siafakas; Sophia Schiza
Journal:  Sleep Breath       Date:  2013-02-07       Impact factor: 2.816

4.  Haematological abnormalities in mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

Review 5.  Cardiological manifestations of mitochondrial respiratory chain disorders.

Authors:  A Berardo; O Musumeci; A Toscano
Journal:  Acta Myol       Date:  2011-06

6.  Bezafibrate Rescues Mitochondrial Encephalopathy in Mice via Induction of Daily Torpor and Hypometabolic State.

Authors:  Jingwei Lyu; Yuying Zhao; Na Zhang; Xuebi Xu; Rui Zheng; Wenfei Yu; Wang Xin; Chuanzhu Yan; Kunqian Ji
Journal:  Neurotherapeutics       Date:  2022-03-25       Impact factor: 6.088

7.  Clinical Characteristics of Early-Onset and Late-Onset Leigh Syndrome.

Authors:  Chan-Mi Hong; Ji-Hoon Na; Soyoung Park; Young-Mock Lee
Journal:  Front Neurol       Date:  2020-04-15       Impact factor: 4.003

Review 8.  Endocrine disorders in mitochondrial disease.

Authors:  Andrew M Schaefer; Mark Walker; Douglass M Turnbull; Robert W Taylor
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.